These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 18632221

  • 1. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
    Niemhom S, Kitazawa S, Kitazawa R, Maeda S, Leopairat J.
    Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
    [Abstract] [Full Text] [Related]

  • 2. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
    Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, Chang AR, van Hasselt CA, Huang DP, To KF.
    Clin Cancer Res; 2002 Aug; 8(8):2612-9. PubMed ID: 12171892
    [Abstract] [Full Text] [Related]

  • 3. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z, Ren Y, Lin SX, Liang YJ, Liang HZ.
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [Abstract] [Full Text] [Related]

  • 4. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH, Huang LC, Hsu YH.
    Anticancer Res; 2002 Aug; 22(6C):4109-13. PubMed ID: 12553040
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ.
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM.
    Cancer; 2003 Jul 15; 98(2):288-91. PubMed ID: 12872347
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

  • 11. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY.
    Cancer; 2007 Dec 15; 110(12):2785-92. PubMed ID: 17960794
    [Abstract] [Full Text] [Related]

  • 12. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D, Srivatanakul P, Karalak A, Ishida T.
    J Clin Virol; 2008 May 15; 42(1):1-6. PubMed ID: 18180201
    [Abstract] [Full Text] [Related]

  • 13. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions.
    Chiles MC, Ai L, Zuo C, Fan CY, Smoller BR.
    Mod Pathol; 2003 Oct 15; 16(10):1014-8. PubMed ID: 14559984
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
    Shieh YS, Shiah SG, Jeng HH, Lee HS, Wu CW, Chang LC.
    Cancer; 2005 Sep 01; 104(5):1013-21. PubMed ID: 15999364
    [Abstract] [Full Text] [Related]

  • 17. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients.
    Wong TS, Chang HW, Tang KC, Wei WI, Kwong DL, Sham JS, Yuen AP, Kwong YL.
    Clin Cancer Res; 2002 Feb 01; 8(2):433-7. PubMed ID: 11839660
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
    Shao JY, Zhang Y, Li YH, Gao HY, Feng HX, Wu QL, Cui NJ, Cheng G, Hu B, Hu LF, Ernberg I, Zeng YX.
    Anticancer Res; 2004 Feb 01; 24(6):4059-66. PubMed ID: 15736452
    [Abstract] [Full Text] [Related]

  • 19. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
    Ben Nasr H, Hamrita B, Batbout M, Gabbouj S, Bouaouina N, Chouchane L, Chahed K.
    Clin Chim Acta; 2010 Sep 06; 411(17-18):1253-7. PubMed ID: 20462505
    [Abstract] [Full Text] [Related]

  • 20. [Expression of CD25+ lymphocytes in nasopharyngeal carcinoma and its association with EBV infection].
    Liu W, Han HX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan 06; 26(1):94-7. PubMed ID: 16495186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.